Published in Ann Surg on December 01, 1991
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res (1996) 1.13
Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation. World J Surg (2008) 0.85
Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci (1998) 0.84
An early single-center experience of portal vein thrombosis in living donor liver transplantation: clinical feature, management and outcome. J Korean Surg Soc (2011) 0.80
Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol (2012) 0.79
Two-year experience of orthotopic liver transplantation in afzalipoor hospital, kerman, southeastern iran. Int J Organ Transplant Med (2012) 0.78
Liver transplantation in the presence of old portal vein thrombosis. Int J Organ Transplant Med (2010) 0.77
Use of Left Gastric Vein as an Alternative for Portal Flow Reconstruction in Liver Transplantation. Case Rep Surg (2016) 0.75
A case report of simultaneous orthotopic liver transplantation and jejunectomy. BMC Surg (2016) 0.75
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION. Surg Gynecol Obstet (1965) 3.15
Liver transplantation in adults. Hepatology (1982) 2.89
Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet (1985) 2.59
Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11
The first 100 liver transplants at UCLA. Ann Surg (1987) 1.84
Color Doppler sonography of the hepatic artery and portal venous system. AJR Am J Roentgenol (1990) 1.50
Evaluation of children for liver transplantation: value of MR imaging and sonography. AJR Am J Roentgenol (1990) 1.43
Infectious complications in liver transplantation. Arch Surg (1988) 1.29
Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg (1991) 1.27
Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg (1989) 1.12
Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits. Surgery (1990) 1.04
Bile duct varices. An alternative to portoportal anastomosis in liver transplantation. Transplantation (1986) 1.04
Selection criteria and decisions in 375 patients with liver disease, considered for liver transplantation during 1977-1985. Liver (1987) 1.01
Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation (1989) 0.97
Porta hepatis: duplex Doppler US with angiographic correlation. Radiology (1987) 0.94
Superior mesenteric vein inflow for liver transplantation when the portal vein is occluded. Surgery (1990) 0.91
Assessment of portal vein patency: comparison of arterial portography and ultrasound scanning. Clin Radiol (1988) 0.88
Portal vein obstruction in patients requiring hepatic resection or transplantation. Am Surg (1984) 0.86
Liver transplantation. Surg Clin North Am (1985) 0.83
Color Doppler imaging of portosystemic shunts. AJR Am J Roentgenol (1990) 0.82
A modified cannulation technique for veno-venous bypass during orthotopic liver transplantation. Transplant Proc (1989) 0.80
Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg (1994) 3.83
Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg (1984) 3.65
Amanita poisoning: treatment and the role of liver transplantation. Am J Med (1989) 3.20
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest (1999) 2.29
Perforation of the gallbladder: a frequently mismanaged condition. Am J Surg (1979) 2.26
Treatment of necrotizing soft tissue infections. The need for a new approach. Am J Surg (1985) 1.97
Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol (1997) 1.91
Ischemia and reperfusion injury in liver transplantation. Transplant Proc (2005) 1.77
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73
Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant (2011) 1.71
Infections in liver transplant recipients. Clin Infect Dis (1995) 1.71
Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation (1995) 1.63
Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1999) 1.63
The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation: a clinical histologic correlation of 34 liver transplants. Hum Pathol (1988) 1.60
Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg (1998) 1.59
Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59
Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53
Moxalactam therapy for bacterial infections. Arch Intern Med (1981) 1.53
Major challenges limiting liver transplantation in the United States. Am J Transplant (2011) 1.50
The diagnosis and management of visceral artery aneurysms. Surgery (1980) 1.49
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48
Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg (1990) 1.45
Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg (1990) 1.43
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? J Vasc Surg (1988) 1.40
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Am J Transplant (2014) 1.40
Mycobacterial infections after pediatric liver transplantation: a report of three cases and review of the literature. J Pediatr Gastroenterol Nutr (1995) 1.39
Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl (2001) 1.35
Liver transplantation today. Ann Intern Med (1986) 1.34
Aortic saddle embolus. A twenty-year experience. Ann Surg (1983) 1.30
Infectious complications in liver transplantation. Arch Surg (1988) 1.29
Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant (2001) 1.29
Carotid artery stenosis - hemodynamic significance and clinical course. JAMA (1981) 1.25
Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet (1995) 1.24
Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23
Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg (1987) 1.22
Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg (2000) 1.21
Pathogenesis of aortoduodenal fistula: experimental and clinical correlates. Surgery (1979) 1.20
Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant (2008) 1.20
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections. Antimicrob Agents Chemother (1984) 1.20
An unusual cause of massive gastrointestinal hemorrhage. Carcinoid tumor of the ileum. JAMA (1978) 1.19
Natural history of nonstenotic, asymptomatic ulcerative lesions of the carotid artery. A further analysis. Arch Surg (1982) 1.18
Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus. Gastroenterology (2000) 1.17
The use of the supraceliac aorta for hepatic arterial revascularization in transplantation of the liver. Surg Gynecol Obstet (1991) 1.17
Effect of prophylactic antibiotics in acute nonperforated appendicitis: a prospective, randomized, double-blind clinical study. Ann Surg (1981) 1.17
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg (1997) 1.16
In situ splitting of the cadaveric liver for transplantation. Transplantation (1997) 1.14
Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation (2001) 1.13
Improved results of liver transplantation in patients with portal vein thrombosis. Arch Surg (1996) 1.12
Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg (1989) 1.12
Orthotopic liver transplantation for hepatobiliary malignancy. Report of three cases of special interest. Transplantation (1986) 1.10
Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms. Arch Surg (1980) 1.09
Splenectomy for hematologic disease. The UCLA experience with 306 patients. Ann Surg (1984) 1.08
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl (2000) 1.05
Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation (1998) 1.05
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05
Hepatic artery reconstruction during liver transplantation. Transplantation (1989) 1.05
Advances in pediatric liver and intestinal transplantation. Am J Surg (2000) 1.04
Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation (1999) 1.04
Variables influencing the outcome following orthotopic liver transplantation. Arch Surg (1987) 1.04
Bile duct varices. An alternative to portoportal anastomosis in liver transplantation. Transplantation (1986) 1.04
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg (1998) 1.03
The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass. J Vasc Surg (1986) 1.02
A simple model to estimate survival after retransplantation of the liver. Transplantation (1999) 1.02
Endoscopic management of biliary fistulas complicating liver transplantation and other hepatobiliary operations. Ann Surg (1993) 1.02
Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol (1991) 1.01
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg (1999) 1.01
Isolated hypogastric artery aneurysms. Arch Surg (1982) 1.01
Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis (2000) 1.00
Operations upon the biliary tract during transplantation of the liver. Surg Gynecol Obstet (1987) 0.99
Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation (1994) 0.98
Congenital arteriovenous malformations. The role of transcatheter arterial embolization. Arch Surg (1983) 0.98
Elastase activity: the role of elastase in aortic aneurysm formation. J Surg Res (1982) 0.98
Matched control study of distal splenorenal and portacaval shunts in the treatment of bleeding esophageal varices. Am J Surg (1979) 0.98
The role of combined liver/kidney transplantation in end-stage hepato-renal disease. Am Surg (1993) 0.98
Selective and nonselective shunts for variceal bleeding. A prospective study of 103 patients. Am J Surg (1984) 0.97
Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc (1990) 0.97
Air embolism associated with veno-venous bypass during orthotopic liver transplantation. Anesthesiology (1987) 0.97
The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg (1992) 0.96
Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation (1998) 0.96
ATF6 mediates a pro-inflammatory synergy between ER stress and TLR activation in the pathogenesis of liver ischemia-reperfusion injury. Am J Transplant (2014) 0.96
Liver transplantation at UCLA. Program development, organization, initiation, and early results. Am J Surg (1986) 0.96
Regeneration-induced accelerated rejection in reduced-size liver grafts. Transplantation (1994) 0.95
Orthotopic liver transplantation for biliary atresia. Evolution of management. Arch Surg (1988) 0.94
Red cell aplasia in children on tacrolimus after liver transplantation. Transplantation (1998) 0.94
Liver transplantation for fulminant hepatic failure in the pediatric patient. Arch Surg (1998) 0.94
Th1 and Th2 cytokines in organ transplantation: paradigm lost? Crit Rev Immunol (1999) 0.94
Branch patch for arterialization of hepatic grafts. Surg Gynecol Obstet (1986) 0.94
Liver transplantation for hepatoblastoma. The American experience. Ann Surg (1991) 0.94
The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection. Transplantation (1991) 0.94
Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience. Ann Surg (1996) 0.93
A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation (1995) 0.93
Diannexin, a novel annexin V homodimer, protects rat liver transplants against cold ischemia-reperfusion injury. Am J Transplant (2007) 0.93
Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation (1990) 0.93
Bleeding esophageal varices and portal vein thrombosis after pancreatic mixed-cell autotransplantation. Surgery (1984) 0.93
Perforin and granzyme B. Cytolytic proteins up-regulated during rejection of rat small intestine allografts. Transplantation (1995) 0.93
Disruption of Type-I IFN pathway ameliorates preservation damage in mouse orthotopic liver transplantation via HO-1 dependent mechanism. Am J Transplant (2012) 0.93
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation (1990) 0.92